"Kaohsiung CGMH NeuroScience Lab MRI and PET schedule"

During the past decade, Kaohsiung Chang Gung Memorial Hospital conducted 306 clinical trials. In the 10-year time frame, 306 clinical trials started and 81 clinical trials were completed, i.e. on average, 26.5% percent of trials that started reached the finish line to date. In the past 5 years, 153 clinical trials started and 64 clinical trials were completed. i.e. 41.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaohsiung Chang Gung Memorial Hospital" #1 sponsor was "Chang Gung Memorial Hospital" with 123 trials, followed by "Eli Lilly and Company" with 19 trials sponsored, "Janssen Research & Development, LLC" with 18 trials sponsored, "Pfizer" with 16 trials sponsored and "BeiGene" with 16 trials sponsored. Other sponsors include 194 different institutions and companies that sponsored additional 115 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaohsiung Chang Gung Memorial Hospital" #1 collaborator was "Chang Gung Memorial Hospital" with 9 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 8 trials as a collaborator, "Merck Sharp & Dohme LLC" with 8 trials as a collaborator, "National Cheng-Kung University Hospital" with 7 trials as a collaborator and "National Taiwan University Hospital" with 7 trials as a collaborator. Other collaborators include 136 different institutions and companies that were collaborators in the rest 104 trials.

According to Clinical.Site data, the most researched conditions in "Kaohsiung Chang Gung Memorial Hospital" are "Hepatocellular Carcinoma" (11 trials), "Stroke" (10 trials), "Carcinoma, Non-Small-Cell Lung" (9 trials), "Alzheimer's Disease" (8 trials) and "Atopic Dermatitis" (7 trials). Many other conditions were trialed in "Kaohsiung Chang Gung Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Kaohsiung Chang Gung Memorial Hospital" are "Drug" (261 trials), "Other" (63 trials), "Device" (27 trials), "Biological" (22 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (87 trials), "Cisplatin" (17 trials), "Carboplatin" (13 trials), "Pembrolizumab" (11 trials) and "Paclitaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "Kaohsiung Chang Gung Memorial Hospital" are 367 trials for "All" genders, 12 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 134 active trials in "Kaohsiung Chang Gung Memorial Hospital". 7 are not yet recruiting, 70 are recruiting, 54 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 174 completed trials in Kaohsiung Chang Gung Memorial Hospital, 1 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Kaohsiung Chang Gung Memorial Hospital, 20 "Phase 1" clinical trials were conducted, 89 "Phase 2" clinical trials and 143 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 60 trials that are defined as “Not Applicable".